(a) Pursuant to clause 8 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, the Director-General of Health, hereby authorise the following persons or class of persons to do any or all of the activities prohibited by clause 7 of the Order.

The authorised persons or class of persons are:

The above persons or classes of persons are authorised to import, supply and sell the following point-of-care tests:

(b) Pursuant to clause 8 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, the Director-General of Health, hereby authorise the following persons or class of persons to use point-of-care tests to test for SARS-CoV-2 or COVID-19:

The persons or class of persons authorised to use point-of-care tests are:

1. All laboratories accredited by International Accreditation New Zealand (IANZ) to ISO 15189 for COVID-19 testing and who provides laboratory testing services to District Health Boards.
2. All NZ District Health Board hospitals.
3. New Zealand Medical Assistance Team (NZMAT).
4. New Zealand Police.
5. Department of Corrections.
6. New Zealand Defence Force.
7. Parliamentary Service.
8. All New Zealand-based businesses with a registered New Zealand Business Number (NZBN).
9. The healthcare workforce including general practices and aged residential care.
10. Government agencies.
11. Non-Government agencies.
12. Pharmacies.

The above persons or classes of persons are authorised to use the following point-of-care tests:

Dated this 3rd day of December 2021.

Dr ASHLEY BLOOMFIELD, Director-General of Health.

Note: This notice revokes and replaces the notice published in the New Zealand Gazette, 2 December 2021, Notice No. 2021-go5180, which incorrectly stated the product number for CareStart COVID-19 Antigen (Nasal) manufactured by Access Bio Inc (United States of America) as “700656” instead of “7006576”.